# A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

> **NCT07533942** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Jazz Pharmaceuticals** · enrollment: 30 (estimated)

## Conditions studied

- Meningioma

## Interventions

- **DRUG:** JZP3507

## Key facts

- **NCT ID:** NCT07533942
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-10-25
- **Final completion:** 2031-10-16
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533942, "A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07533942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*